← FDA Drug Approvals (Drugs@FDA)

HETLIOZ LQ

NDA · New Drug Application · Sponsor: VANDA PHARMS INC · Approved 2020-12-01

Drug application

FDA Application #

NDA214517

Application type

New Drug Application

Brand name

HETLIOZ LQ

Generic name

TASIMELTEON

Active ingredients

TASIMELTEON

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

VANDA PHARMS INC

Manufacturer

Vanda Pharmaceuticals Inc.

First approval

2020-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown